BusinessEsperion Therapeutics to Present at the Stifel 2016 Healthcare ConferenceBy Nasdaq OMXNov 9, 2016, 9:30 PM UTC
BusinessEsperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Third Quarter 2016 Financial ResultsBy Nasdaq OMXNov 3, 2016, 8:06 PM UTC
BusinessEsperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Third Quarter 2016 Financial ResultsBy Nasdaq OMXNov 3, 2016, 8:06 PM UTC
BusinessEsperion Therapeutics to Present at the Credit Suisse 25th Annual Healthcare ConferenceBy Nasdaq OMXNov 1, 2016, 8:30 PM UTC
BusinessEsperion Therapeutics to Present at the Barclays Global Healthcare ConferenceBy Nasdaq OMXMar 8, 2016, 9:30 PM UTC
BusinessEsperion Therapeutics Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter and Full Year 2015 Financial ResultsBy Nasdaq OMXFeb 25, 2016, 9:05 PM UTC
BusinessEsperion Therapeutics to Present at the 2016 RBC Capital Markets Global Healthcare ConferenceBy Nasdaq OMXFeb 16, 2016, 9:30 PM UTC
BusinessEsperion Therapeutics Announces Initiation of Phase 3 Clinical Program With Long-Term Safety and Tolerability StudyBy Nasdaq OMXJan 13, 2016, 1:30 PM UTC